chenodeoxycholic acid has been researched along with Aura in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (33.33) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Arawaka, S; Kato, T; Kawanami, T; Koyama, S; Saito, N; Tanji, H; Wada, M | 1 |
Ishikawa, A; Kondo, R; Miyatake, T; Wakamatsu, N; Yuasa, T | 1 |
3 other study(ies) available for chenodeoxycholic acid and Aura
Article | Year |
---|---|
A case of cerebrotendinous xanthomatosis presenting with epilepsy as an initial symptom with a novel V413D mutation in the CYP27A1 gene.
Topics: Adolescent; Brain; Chenodeoxycholic Acid; Cholagogues and Choleretics; Cholestanetriol 26-Monooxygenase; Cholestanol; DNA; Electroencephalography; Epilepsy; Exons; Female; Humans; Magnetic Resonance Imaging; Mutation; Neurologic Examination; Xanthomatosis, Cerebrotendinous | 2012 |
Research findings of potential value to the practitioner.
Topics: Breast Neoplasms; Chenodeoxycholic Acid; Cholelithiasis; Epilepsy; Female; Heparin; Humans; Male; National Institutes of Health (U.S.); Pulmonary Embolism; Research; United States | 1976 |
[A case of cerebrotendinous xanthomatosis with spastic paraparesis, epilepsy, and bradykinesia].
Topics: Adult; Brain Diseases; Chenodeoxycholic Acid; Epilepsy; Female; Humans; Movement Disorders; Muscular Diseases; Paraparesis, Tropical Spastic; Tendons; Xanthomatosis | 1991 |